- Products >
- Valve for the pharmaceutical industry
Valves for the pharmaceutical industry
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
DN: 10 nm - 60 nm
Pressure: 0.2 bar - 10 bar
Temperature : -10 °C - 120 °C
The A470 leakage butterfly valve can be used in most liquid product applications in the food-processing, pharmaceutical and chemical industries. The valve ...
DN: 8 mm - 150 mm
Full bore Pressure class PN16 to PN100 Internal surface finish Ra 0,4 (ball and ends) Ball in low ferrite stainless steel (1.4435) Orbital welding end in low ferrite stainless steel (1.4435) USP Class VI seats (TFM1600®) Option: ...
Meca-Inox
DN: 8 mm - 65 mm
CIP lines and corrosive media, all wetted parts in Alloy C22 Full bore and reduced bore Pressure class PN50 to PN100 Option: cavity fillers, degreased for O2 application acc. to EN12300 Other Alloy C22 lines of product available: PED ...
Meca-Inox
DN: 15 mm - 200 mm
Pressure: 1 bar
Temperature : 0 °C - 280 °C
Flange connection acc. to EN1092-1 Face-to-face EN558 Series 14 short pattern Pressure rating; PN40 PN16 Pneumatic and electrical actuation Option: extended stem for insulation
Meca-Inox
DN: 8 mm - 200 mm
Pressure: 1 bar
Temperature : -30 °C - 280 °C
Full bore and reduced bore Pressure class PN16 to PN100 Pneumatic and electrical actuation Any stainless steel end connection available (BW, orbital, clamp, …)
Meca-Inox
DN: 8 mm - 200 mm
Pressure: 1 bar
Temperature : -80 °C - 190 °C
Full bore and reduced bore Pressure rating PN16 to PN100 Pneumatic and electrical actuation Any stainless steel end connection available (BW, orbital, clamp, …) Gland packing and body seal in fluorosilicon to increase tightness during ...
Meca-Inox
Your suggestions for improvement:
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining